Author:
Lakha Shehnaz Fatima,Mailis Angela
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Horsley JS. Pentothal sodium in mental hospital practice. BMJ. 1936;1(3931):938.
2. Mailis A, Taylor AE, Shoichet R, Vanderlinden RG. Use of sodium amytal interview in the assessment of complex chronic pain patients. Clin J Pain. 1988;4(3):135–42.
3. Mailis A, Plapler P, Ashby P, Shoichet R, Roe S. Effect of intravenous sodium amytal on cutaneous limb temperatures and sympathetic skin responses in normal subjects and pain patients with and without complex regional pain syndromes (type I and II). I. Pain. 1997;70(1):59–68.
4. Mailis A, Amani N, Umana M, Basur R, Roe S. Effect of intravenous sodium amytal on cutaneous sensory abnormalities, spontaneous pain and algometric pain pressure thresholds in neuropathic pain patients: a placebo-controlled study. II. Pain. 1997;70(1):69–81.
5. Mailis A, Papagapiou M, Umana M, Cohodarevic T, Nowak J, Nicholson K. Unexplainable non-dermatomal somatosensory deficits in patients with chronic non-malignant pain in the context of litigation/compensation: a role for involvement of central factors. J Rheumatol. 2001;28(6):1385–93.